|
|
|
|
Molecular Pharmacology, Vol 20, 159-164, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics
-Methyldopa
1 Department of Biochemistry, Emory University, Atlanta, Georgia 30322, and Department of Forensic Medicine, Karolinska
Institute, Stockholm, Sweden
-Methyldopa stimulates the conversion of the primary catalase-peroxide complex (Compound I) to the catalytically inactive secondary catalase-peroxide complex (Compound
II) in solutions of purified catalase as well as in suspensions of isolated hepatocytes. The
rate of Compound II formation is dependent upon both the rate of H2O2 generation and
the concentration of
-methyldopa. The catalase-dependent oxidation of
-methyldopa
to the corresponding dihydroxyindole nucleus occurs much more rapidly than the formation of Compound II and suggests that the catalase-dependent one-electron oxidation
of
-methyldopa may initiate a free radical process. These reactions may be important in
-methyldopa-induced hepatotoxicity.